The following data is part of a premarket notification filed by Sooil Development Co., Ltd. with the FDA for Dana Diabecare Ii Insulin Pump & Superline-easyrelease, Soft-release-st, & Soft-release-r Infusion Sets.
Device ID | K022317 |
510k Number | K022317 |
Device Name: | DANA DIABECARE II INSULIN PUMP & SUPERLINE-EASYRELEASE, SOFT-RELEASE-ST, & SOFT-RELEASE-R INFUSION SETS |
Classification | Pump, Infusion, Insulin |
Applicant | SOOIL DEVELOPMENT CO., LTD. 49 PLAIN ST. North Attleboro, MA 02760 |
Contact | Cynthia J.m. Nolte |
Correspondent | Cynthia J.m. Nolte SOOIL DEVELOPMENT CO., LTD. 49 PLAIN ST. North Attleboro, MA 02760 |
Product Code | LZG |
CFR Regulation Number | 880.5725 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Special |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2002-07-17 |
Decision Date | 2002-08-02 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
08809220580048 | K022317 | 000 |
08809220580031 | K022317 | 000 |
08809220580017 | K022317 | 000 |
18809220580434 | K022317 | 000 |